Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

AUTOMATED ASSESSMENT OF TIME-DEPENDENT INHIBITION OF HUMAN CYTOCHROME P450 ENZYMES USING LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY ANALYSIS

Anthony Atkinson, Jane R. Kenny and Ken Grime
Drug Metabolism and Disposition November 2005, 33 (11) 1637-1647; DOI: https://doi.org/10.1124/dmd.105.005579
Anthony Atkinson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jane R. Kenny
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ken Grime
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 33 no. 11 1637-1647
DOI 
https://doi.org/10.1124/dmd.105.005579
PubMed 
16049126

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received May 23, 2005
  • Accepted July 26, 2005
  • Published online October 26, 2005.

Article Versions

  • Earlier version (July 27, 2005 - 10:28).
  • You are viewing the most recent version of this article.
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Anthony Atkinson,
  2. Jane R. Kenny and
  3. Ken Grime
  1. Department of Physical and Metabolic Science, AstraZeneca R&D Charnwood, Loughborough, United Kingdom
  1. Address correspondence to:
    Ken Grime, Department of Physical and Metabolic Science, AstraZeneca R&D Charnwood, Bakewell Road, Loughborough, LE11 5RH, UK. E-mail: ken.grime{at}astrazeneca.com
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: August 2017 to March 2023

AbstractFullPdf
Aug 201722533
Sep 201742624
Oct 201702512
Nov 201713717
Dec 20172235
Jan 201812213
Feb 201821622
Mar 201801514
Apr 201803517
May 201812313
Jun 20180275
Jul 201802016
Aug 201802836
Sep 201801720
Oct 201802327
Nov 201803727
Dec 2018331410
Jan 201917723
Feb 201917711
Mar 201925619
Apr 201934612
May 201928616
Jun 201911415
Jul 201928413
Aug 2019221012
Oct 201922211
Nov 201930511
Dec 2019221712
Jan 20202646
Feb 20202747
Mar 20202263
May 20201472
Jun 20202363
Jul 20202824
Aug 20201505
Sep 20203123
Oct 202025114
Nov 20202139
Dec 20202077
Jan 202128246
Feb 202130319
Mar 202137106
Apr 20213065
May 20211652
Jun 202127187
Jul 20212543
Aug 202122103
Sep 202116105
Oct 20212235
Nov 20216367
Dec 20213562
Jan 20222245
Feb 20221089
Mar 20221557
Apr 20221472
May 20223222
Jun 20223711
Jul 202231210
Aug 202237114
Sep 20222284
Oct 202222113
Nov 202240613
Dec 20221835
Jan 20235954
Feb 20232313
Mar 202314811

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 33 (11)
Drug Metabolism and Disposition
Vol. 33, Issue 11
1 Nov 2005
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
AUTOMATED ASSESSMENT OF TIME-DEPENDENT INHIBITION OF HUMAN CYTOCHROME P450 ENZYMES USING LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY ANALYSIS
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

AUTOMATED ASSESSMENT OF TIME-DEPENDENT INHIBITION OF HUMAN CYTOCHROME P450 ENZYMES USING LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY ANALYSIS

Anthony Atkinson, Jane R. Kenny and Ken Grime
Drug Metabolism and Disposition November 1, 2005, 33 (11) 1637-1647; DOI: https://doi.org/10.1124/dmd.105.005579

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

AUTOMATED ASSESSMENT OF TIME-DEPENDENT INHIBITION OF HUMAN CYTOCHROME P450 ENZYMES USING LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY ANALYSIS

Anthony Atkinson, Jane R. Kenny and Ken Grime
Drug Metabolism and Disposition November 1, 2005, 33 (11) 1637-1647; DOI: https://doi.org/10.1124/dmd.105.005579
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Metabolic enzymes in nintedanib metabolism
  • Mechanism of AO Inactivation by Hydralazine
  • Warfarin PBPK modeling with target binding
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics